Domino’s Pizza and Precision Tracking have reached a settlement on the eve of trial in a hard-fought battle by the US pizza giant to invalidate two of the Australian tech startup’s patents covering a GPS system that helps customers locate delivery drivers in real-time.
ASIC has successfully opposed a Federal Court judge’s push to appoint an independent referee in its case against AMP Financial Planning over alleged insurance churning.
Liquidators for Dick Smith don’t want potential group members in two class actions against the failed retailer to learn about a new registration deadline by email, saying it would amount to spam and harassment.
Food manufacturer Goodman Fielder has shot back against claims by rival Conga Foods that six of its trade marks for pasta products should be deregistered for non-use.
Industrial filter manufacturer Vokes will launch a cross claim against rival Laminar Air Flow, arguing a 17-year old error which led to six of its trade marks being revoked can still be undone.
Crown Resorts has accused the NSW government of breaching its contractual obligations by “spruiking” to construction firms for development at central Barangaroo that would obstruct its views of the Sydney Harbour Bridge and the Opera House.
Aurizon has won a request to view documents from Qube Holdings in the ACCC’s case alleging it reached an anti-competitive agreement with Pacific National for the sale of its intermodal freight business, as it pushes back against the competition regulator’s claim that there were other buyers vying for the business.
ASIC has locked horns with a Federal Court judge over his proposal to appoint an independent referee in its case against AMP over insurance rewriting, with the regulator arguing the move would lead to delay and duplication of costs.
A Federal Court judge has expressed her disbelief at a cross claim by generic drug maker Sandoz against Danish multinational H Lundbeck, as the court begins to weigh arguments over damages owed to Lundbeck in the long-running patent case over its blockbuster anti-depressant Lexapro.
AMP’s financial planning unit has shot back at allegations by the corporate watchdog that a group of planners engaged in so-called life insurance rewriting, admitting only that one of its army of advisers broke the law.